agilon health, inc. (AGL) Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount

agilon health, inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount

agilon health, inc. (AGL) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $75.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets

us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-25

• agilon health, inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $75.30M, a 19.90% increase from fiscal 2024.
• agilon health, inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $62.80M, a 21.47% increase from fiscal 2023.
• agilon health, inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $51.70M, a 3.54% decline from fiscal 2022.
• agilon health, inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $53.60M, a 59.88% decline from fiscal 2021.